S&T Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.69M | Sell |
21,548
-5,749
| -21% | -$1.28M | 1.75% | 14 |
|
|
2025
Q4 | $6.24M | Sell |
27,297
-6,090
| -18% | -$1.39M | 1.97% | 13 |
|
|
2025
Q3 | $7.73M | Sell |
33,387
-4,325
| -11% | -$881K | 2.17% | 11 |
|
|
2025
Q2 | $7M | Sell |
37,712
-3,264
| -8% | -$607K | 2.13% | 12 |
|
|
2025
Q1 | $8.59M | Sell |
40,976
-761
| -2% | -$148K | 2.81% | 3 |
|
|
2024
Q4 | $7.42M | Sell |
41,737
-5,574
| -12% | -$1.02M | 2.37% | 9 |
|
|
2024
Q3 | $9.34M | Sell |
47,311
-9,441
| -17% | -$1.76M | 2.45% | 6 |
|
|
2024
Q2 | $9.73M | Sell |
56,752
-14,415
| -20% | -$2.39M | 2.48% | 4 |
|
|
2024
Q1 | $13M | Sell |
71,167
-11,057
| -13% | -$1.91M | 2.49% | 6 |
|
|
2023
Q4 | $12.7M | Sell |
82,224
-3,358
| -4% | -$490K | 2.35% | 7 |
|
|
2023
Q3 | $12.8M | Sell |
85,582
-2,954
| -3% | -$434K | 2.46% | 6 |
|
|
2023
Q2 | $11.9M | Sell |
88,536
-6,034
| -6% | -$885K | 2.15% | 12 |
|
|
2023
Q1 | $15.1M | Sell |
94,570
-5,942
| -6% | -$908K | 2.72% | 4 |
|
|
2022
Q4 | $16.2M | Sell |
100,512
-1,027
| -1% | -$157K | 3% | 4 |
|
|
2022
Q3 | $13.6M | Sell |
101,539
-2,701
| -3% | -$388K | 2.63% | 5 |
|
|
2022
Q2 | $16M | Sell |
104,240
-9,272
| -8% | -$1.42M | 2.81% | 2 |
|
|
2022
Q1 | $18.4M | Sell |
113,512
-3,755
| -3% | -$545K | 2.78% | 3 |
|
|
2021
Q4 | $15.9M | Buy |
117,267
+1,425
| +1% | +$168K | 2.32% | 9 |
|
|
2021
Q3 | $12.5M | Buy |
115,842
+8,206
| +8% | +$938K | 1.94% | 12 |
|
|
2021
Q2 | $12.1M | Buy |
107,636
+4,487
| +4% | +$505K | 1.88% | 15 |
|
|
2021
Q1 | $11.2M | Sell |
103,149
-2,529
| -2% | -$271K | 1.82% | 17 |
|
|
2020
Q4 | $11.3M | Sell |
105,678
-5,191
| -5% | -$499K | 2.03% | 13 |
|
|
2020
Q3 | $9.71M | Sell |
110,869
-9,917
| -8% | -$934K | 2.22% | 9 |
|
|
2020
Q2 | $11.9M | Sell |
120,786
-18
| -0% | -$1.58K | 2.7% | 4 |
|
|
2020
Q1 | $9.2M | Sell |
120,804
-5,340
| -4% | -$455K | 2.54% | 6 |
|
|
2019
Q4 | $11.2M | Buy |
126,144
+185
| +0.1% | +$15.4K | 2.29% | 9 |
|
|
2019
Q3 | $9.54M | Buy |
+125,959
| New | +$8.64M | 2.06% | 9 |
|
|
2018
Q1 | – | Sell |
-2,342
| Closed | -$227K | – | 92 |
|
|
2017
Q4 | $227K | Sell |
2,342
-31
| -1% | -$2.92K | 0.04% | 84 |
|
|
2017
Q3 | $211K | Buy |
+2,373
| New | +$181K | 0.04% | 85 |
|
|
2017
Q2 | – | Sell |
-3,361
| Closed | -$219K | – | 96 |
|
|
2017
Q1 | $219K | Sell |
3,361
-1,272
| -27% | -$80K | 0.04% | 79 |
|
|
2016
Q4 | $290K | Sell |
4,633
-198
| -4% | -$12.1K | 0.05% | 76 |
|
|
2016
Q3 | $304K | Sell |
4,831
-1,129
| -19% | -$73.1K | 0.05% | 71 |
|
|
2016
Q2 | $369K | Sell |
5,960
-9,577
| -62% | -$584K | 0.06% | 69 |
|
|
2016
Q1 | $887K | Sell |
15,537
-3,129
| -17% | -$174K | 0.15% | 60 |
|
|
2015
Q4 | $1.11M | Sell |
18,666
-532
| -3% | -$30.6K | 0.17% | 62 |
|
|
2015
Q3 | $1.04M | Sell |
19,198
-879
| -4% | -$57.2K | 0.16% | 65 |
|
|
2015
Q2 | $1.35M | Sell |
20,077
-484
| -2% | -$31.6K | 0.2% | 63 |
|
|
2015
Q1 | $1.2M | Sell |
20,561
-3,491
| -15% | -$211K | 0.18% | 62 |
|
|
2014
Q4 | $1.57M | Sell |
24,052
-564
| -2% | -$35.6K | 0.23% | 63 |
|
|
2014
Q3 | $1.42M | Sell |
24,616
-1,371
| -5% | -$76.1K | 0.21% | 63 |
|
|
2014
Q2 | $1.47M | Sell |
25,987
-1,446
| -5% | -$75.9K | 0.22% | 64 |
|
|
2014
Q1 | $1.41M | Buy |
27,433
+3,020
| +12% | +$153K | 0.2% | 74 |
|
|
2013
Q4 | $1.29M | Sell |
24,413
-9,796
| -29% | -$481K | 0.18% | 74 |
|
|
2013
Q3 | $1.53M | Sell |
34,209
-500
| -1% | -$22.2K | 0.24% | 71 |
|
|
2013
Q2 | $1.43M | Buy |
+34,709
| New | +$1.52M | 0.25% | 69 |
|
Other funds holding ABBV
VCM
VPM
S&T Bank's ABBV Position: Q1 2026 in Review
S&T Bank reduced its AbbVie (ABBV) stake by 21% in Q1 2026, selling an estimated $1.28M and leaving 21,548 shares worth $4.69M. The position accounts for 1.75% of the portfolio, ranked #14.
S&T Bank first reported a position in ABBV in Q2 2013 and has held it in 45 quarters since. The position peaked at $18.4M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- S&T Bank held 21,548 shares of AbbVie worth $4.69M as of Q1 2026.
- S&T Bank sold 5,749 AbbVie shares in Q1 2026, an estimated $1.28M.
- AbbVie made up 1.75% of S&T Bank's portfolio in Q1 2026, its #14 holding.
- S&T Bank first reported a position in AbbVie in Q2 2013 and has held it in 45 quarters since.
- S&T Bank's AbbVie position peaked at $18.4M in Q1 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on S&T Bank's 13F filing for Q1 2026, filed 13 May 2026.